Anita Chudecka-Głaz

6PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Haematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 20, 2024
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri

|Mar 28, 2018
Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Małgorzata Wężowska

|Mar 09, 2018
Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

Aneta Cymbaluk-Płoska, Anita Chudecka-Głaz, Ewa Pius-Sadowska

|Nov 02, 2017
Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer.

Aneta Cymbaluk-Płoska, Anita Chudecka-Głaz, Ewa Pius-Sadowska

|Feb 10, 2017
HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases.

Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Aleksandra Strojna

|Sep 15, 2016
The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania.

J Menkiszak, V Sopik, A Chudecka-Głaz

Pageof 1

Frequent Collaborators

2 joint publications

Aneta Cymbaluk-Płoska

2 joint publications

Ewa Pius-Sadowska

2 joint publications

Bogusław Machaliński

1 joint publications

Alexander B Olawaiye